Traditional multi-omics, include genomics, transcriptomics, proteomics, and metabolomics, to reveal critical biological information. However, one essential layer is still missing: translation, the step that determines which RNAs are converted into proteins. Without measuring protein synthesis, multi-omics frameworks risk incomplete or misleading conclusions. This whitepaper explains why translatomics is now indispensable for accurate biological interpretation and predictive modelling.
RNA abundance does not reliably predict protein output, and protein measurements alone cannot explain the regulatory decisions that shape the proteome. Translation acts as the gatekeeper between potential and real cellular function.
Ribosome profiling (Ribo-seq) provides genome-wide, nucleotide-resolution views of translation, uncovering phenomena invisible to RNA-seq or proteomics; such as uORFs, microproteins, ribosome pausing, and selective translational responses to stress. These insights make Ribo-seq a transformative addition to the multi-omics toolbox.
This whitepaper offers a concise overview of:
This whitepaper is essential for researchers in pharma, biotech, oncology, immunology, systems biology, and for anyone integrating multi-omics data or developing predictive models of cellular behaviour.
Download the Whitepaper